Executive Chair of InnoScot Health, Graham Watson, analyses the rise of the robots across Scotland’s healthcare ecosystem and highlights the huge potential for transforming patient outcomes.
GIt is no coincidence that Scottish healthcare continues to invest in robotic-assisted surgery (RAS) given the sustained drip-feed of success stories that has emerged over recent years. Following an initial announcement of fresh investment by the Scottish Government in 2021 that would see surgical robots based in NHS Greater Glasgow and Clyde, NHS Lothian, NHS Tayside, NHS Grampian, NHS Fife, NHS Golden Jubilee and NHS Highland, rollout has continued to other boards.
A game-changing investment of some £25m to date has been vital to efficiency by allowing for more advanced treatment than was previously possible, among many other additional benefits. Indeed, the forward-thinking strategy continues to gift human surgeons enhanced precision and control, leading to faster patient recovery, reduced pain, and lower risk of infection.
The direction of travel is now clear — transforming patient outcomes, easing waiting list pressures, enhancing equity of access — and eventually RAS will become the standard for many operations, supplementing the country's expert surgeons. There is so much potential, including AI integration to enhance imaging, analyse patient data for optimal personalised approaches, and support more autonomous, complex, and remote procedures.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
